US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

647.78

+7.421.16%

Number of Gainers:92

Number of Losers:62

Number of Flat:13

PE:- -

High:661.91

Open:644.52

Low:643.67

Close:640.36

Volume:265.79M

Turnover:7.98B

Market Cap:485.18B

Float Cap:350.02B

Loading ...

Analysts Conflicted on These Communication Services Names: RDE (GIFT), Kanzhun Ltd Sponsored (BZ) and Zillow Group Class A (ZG)

Nexxen International Is Maintained at Buy by BTIG

LegalZoom.com Introduces AI-Powered Grant Finder Tool

MT Newswires Live

Digital Brands announces $500,000 in estimated lost revenue from counterfeiting

Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Hyperfine (HYPR)

Digital Brands Group flags USD 0.5 million counterfeit revenue exposure in AI monitoring deployment with Herschel Supply Co

A research firm's 'obituary' for software stocks vaporized billions. Here's the part the market is finally admitting.

Chemomab Therapeutics sees cash runway through 1Q27

Kanzhun Limited Announces Shareholder Return Target Through Dividend Distribution And Extension And Upsizing Of Share Repurchase Program

COMEX Copper Futures Plunge 3.1% to $5.419 per Pound

Mobix Labs Selected for Smart Munitions Anti-Drone Feasibility Program

Press Release: Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

Press Release: Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

Kanzhun announces shareholder return target

Capital Group Reduces Stake in BOSS ZHIPIN-W by Approximately 2.65 Million Shares at Average Price of HK$56.87

Aveanna Healthcare Posts Strong Q4, Affirms 2026 Outlook

Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Aveanna sees FY26 revenue $2.54B-$2.56B, consensus $2.56B

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4539/news?page=30"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":647.7755,"timestamp":1774468799999,"preClose":640.35693,"halted":0,"volume":265793245,"delay":0,"changeRate":0.011585,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":7.418579,"latestTime":"03-25 16:00:00 EDT","open":644.5246,"high":661.9143,"low":643.67145,"amount":7984666943.559445,"amplitude":0.028489,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774483200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.496655,"peRate":180.122567,"turnoverRate":0.018891,"increases":92,"decrements":62,"flats":8,"marketCap":485177125079.25,"floatMarketCap":350018730519.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":661.9143,"amplitude":0.028489,"preClose":640.35693,"low":643.67145,"pbRate":"5.496655","latestPrice":647.7755,"volume":265793245,"delay":0,"open":644.5246,"prevYearClose":881.5255,"prevWeekClose":652.8748,"prevMonthClose":663.4647,"prevQuarterClose":881.5255,"fiveDayClose":665.3867,"twentyDayClose":663.3362,"sixtyDayClose":917.1801,"secType":"PLATE","market":"US","turnoverRate":0.018891,"peRate":180.122567,"marketCap":485177125079.25,"floatMarketCap":350018730519.875,"timestamp":1774468799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":92,"down":62,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:30,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620225629","title":"Analysts Conflicted on These Communication Services Names: RDE (GIFT), Kanzhun Ltd Sponsored (BZ) and Zillow Group Class A (ZG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225629","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225629?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:10","pubTimestamp":1773925831,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Communication Services sector with new ratings on RDE (GIFT), Kanzhun Ltd Sponsored (BZ) and Zillow Gro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-communication-services-names-rde-gift-kanzhun-ltd-sponsored-bz-and-zillow-group-class-a-zg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-communication-services-names-rde-gift-kanzhun-ltd-sponsored-bz-and-zillow-group-class-a-zg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4130","LU0359201612.USD","BK4585","BK4563","IE00B29SXG58.USD","BK4548","BK4505","BK4535","LU1023057109.AUD","GIFT","BK4588","LU0359202008.SGD","BZ","WIMI","BK4526","LU2039709279.SGD","BK4077","LU1688375341.USD","BK4009","BK4509","BK4079","Z","BK4539","BK4551","BK4503"],"gpt_icon":0},{"id":"2620225223","title":"Nexxen International Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225223","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225223?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:04","pubTimestamp":1773925440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NEXN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 09:04 ET (13:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXN","BK4009","BK4539"],"gpt_icon":0},{"id":"2620223171","title":"LegalZoom.com Introduces AI-Powered Grant Finder Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2620223171","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620223171?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:02","pubTimestamp":1773925342,"startTime":"0","endTime":"0","summary":"LegalZoom.com  said Thursday that it has introduced artificial intelligence-powered Grant Finder tool to support small business owners in discovering financing opportunities.The new tool simplifies the process for entrepreneurs to evaluate grant programs customized to their business needs, the company said.LegalZoom.com said there is no sign-up or payment required for Grant Finder.Shares of the company were up 3% in recent Thursday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","BK4123","BK4539","LZ"],"gpt_icon":0},{"id":"2620223950","title":"Digital Brands announces $500,000 in estimated lost revenue from counterfeiting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620223950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620223950?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:55","pubTimestamp":1773924934,"startTime":"0","endTime":"0","summary":"Digital Brands (DBGI) announced initial findings from its AI powered brand protection deployment with Herschel Supply Co., following the previously...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/digital-brands-announces-500000-in-estimated-lost-revenue-from-counterfeiting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/digital-brands-announces-500000-in-estimated-lost-revenue-from-counterfeiting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIYY","BK4539","BK4588","BK4122","BK4023","BK4587","BK4094","DBGI","BK4585","BK4543","AI","BK4551","BK4528"],"gpt_icon":0},{"id":"2620223534","title":"Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Hyperfine (HYPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620223534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620223534?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:50","pubTimestamp":1773924626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jade Biosciences (JBIO), Hyperfine (HYPR) and Aveann...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-jade-biosciences-jbio-hyperfine-hypr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-jade-biosciences-jbio-hyperfine-hypr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","XBI","BK4539","BK4588","BLSX","BK4581","BK4082","BK4585","LABU","BK4112","HYPR","LU0029874061.USD","BK4139","JBIO","BLSG"],"gpt_icon":0},{"id":"2620228483","title":"Digital Brands Group flags USD 0.5 million counterfeit revenue exposure in AI monitoring deployment with Herschel Supply Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228483?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:40","pubTimestamp":1773924014,"startTime":"0","endTime":"0","summary":"Digital Brands Group said its AI-driven brand protection deployment with Herschel Supply identified counterfeit activity representing more than USD 0.5 million in estimated lost revenue exposure from unauthorized listings and brand misuse across global digital marketplaces.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Digital Brands Group Inc. published the original content used to generate this news brief via Business Wire  on March 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLM6XWY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4094","BK4122","DBGI","BK4539"],"gpt_icon":0},{"id":"2620724016","title":"A research firm's 'obituary' for software stocks vaporized billions. Here's the part the market is finally admitting.","url":"https://stock-news.laohu8.com/highlight/detail?id=2620724016","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620724016?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:19","pubTimestamp":1773922740,"startTime":"0","endTime":"0","summary":"The Citrini selloff wasn't panic - it was an X-ray. The 'smart money' is quietly exiting the tech sectors AI is disrupting.A recent bombshell report on AI tech tanked shares of vulnerable software and financial services companies.Citrini Research's report detailed ways that AI tech could dominate and disrupt. You still have time to reposition your portfolio.Citrini Research, the No. 1 finance newsletter on Substack with close to 200,000 subscribers, published a scenario analysis about artificial intelligence. It's a scenario, not a prediction.\"The 2028 Global Intelligence Crisis\" published last month imagines AI unleashing both a productivity boom and widespread unemployment. Cue the AI scare: Michael Burry of \"Big Short\" fame posts on X: \"And you think I'm bearish.\" Commentator Nassim Taleb amplifies the volume with bankruptcy warnings.Start with white-collar employment. Information-worker jobs are already down roughly 8% from their 2023 peak. Big Tech has been executing round after r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU2430703178.SGD","IE00BDRTCR15.USD","LU2290526834.HKD","IE00B775H168.HKD","HK0000320223.HKD","LU0308772762.SGD","IE00B775SV38.USD","LU1043141123.HKD","LU0979878070.USD","LU2357305700.SGD","BK4527","IE00B19Z9P08.USD","LU1914381329.SGD","LU0823434583.USD","BK4227","LU1066051225.USD","LU1674673428.USD","LU2028103732.USD","LU2125909759.SGD","LU0345770308.USD","IE00BDCRKT87.USD","LU1323610961.USD","LU1236620750.USD","LU2746668974.SGD","LU0187121727.USD","LU2087621335.USD","NVDX","LU2764263203.CNY","LU0029864427.USD","2NVD.UK","LU2592432038.USD","IE00B3QW5Z07.USD","SG9999018857.SGD","LU1923622291.USD","NVDS","IE00BYXW3230.USD","BK4588","IE0009G5SDU7.USD","LU2089284900.SGD","LU0345769631.USD","IE00B19Z8W00.USD","IE00BWXC8680.SGD","LU2097344357.USD","LU0689626769.HKD","NVD2.UK","LU0472753341.HKD","BK4166","LU2168564222.USD","IE00B64PRP62.GBP","IE0004086264.USD","LU0130517989.USD","LU1861220207.SGD","LU0109391861.USD","LU0345768740.USD","LU2063271972.USD","LU2249611893.SGD","LU1923622614.USD","LU1670756490.USD","LU0251132253.USD","LU0157215616.USD","DIPS","LU1988902786.USD","LU2023250504.SGD","LU0980610538.SGD","LU2357125470.USD","IE00BJTD4N35.SGD","LU2764262908.HKD","LU0426417589.USD","LU0256863811.USD","BK4549","LU2092627202.USD","LU0347712357.USD","BK4613","LU0130102774.USD","LU1623119135.USD","LU2089985449.USD","LU0048573561.USD","NVDQ","LU1791710582.SGD","HK0000914660.USD","IE00BJTD4V19.USD","LU0444971666.USD","BK4559","LU1429558221.USD","BK4592","IE000ITXATA3.USD","IE00BQXX3F31.USD","NVDU","LU1935043536.SGD","LU0323591593.USD","LU0158827948.USD","LU2430703095.HKD","IE00B4YYXB79.USD","IE00BJJMRX11.SGD","LU1861217088.USD","LU2360106780.USD","LU0320765059.SGD","LU1548497426.USD","LU2065171402.SGD","LU1116320737.USD","IE00B1BXHZ80.USD","LU1228905037.USD","LU2361045086.USD","IE0009354923.USD","LU1699723380.USD","LU0057025933.USD","LU1202635105.USD","LU0274383776.USD","LU2360107168.USD","IE0009356076.USD","IE00B3SWFQ91.USD","LU0345770993.USD","IE00B5TLWC47.USD","LU1046421795.USD","IE00B7KXQ091.USD","LU2168564149.EUR","LU1633808545.USD","SGXZ41872573.SGD","LU1066053197.SGD","LU0070217475.USD","LU1244550577.SGD","IE0003U64NQ7.SGD","LU1934455194.USD","LU2602419157.SGD","LU0061475181.USD","LU0820561909.HKD","LU2023251221.USD","LU1435385759.SGD","LU2403377893.USD","LU1400636657.SGD","IE00B3S45H60.SGD","LU2271345857.HKD","BK4551","LU1917777945.USD","LU0823417737.USD","LU1861220033.SGD","LU0251131958.USD","LU1868837136.USD","NVII","LU0511384066.AUD","LU1935042488.USD","LU0868494617.USD","3NVD.UK","LU1074936037.SGD","LU1037948897.HKD","LU0528227936.USD","LU2433249047.HKD","NVDD","LU1069344957.HKD","BK4529","LU1935042215.USD","LU0943347566.SGD","LU1280957306.USD","NVDW","LU0965509283.SGD","LU2458330243.SGD","IE00B19Z8X17.USD","LU1868837300.USD","LU1267930730.SGD","LU0170899867.USD","LU1992135399.USD","LU0256863902.USD","LU0097036916.USD","LU2092937148.SGD","LU0861579265.USD","BK4589","IE00B1XK9C88.USD","LU0690374961.EUR","SG9999001424.SGD","LU1642822529.SGD","NVDB","BK4598","LU2326559502.SGD","LU1821325948.USD","LU2456880835.USD","LU0823414478.USD","LU2272731600.USD","IE0004445239.USD","LU1691799644.USD","LU0079474960.USD","LU0265550359.USD","LU2264538146.SGD","LU2491049909.HKD","IE000M9KFDE8.USD","IE00B7SZLL34.SGD","LU2054465674.USD","LU2265009873.SGD","SG9999014914.USD","NVDY","LU0081259029.USD","SG9999004303.SGD","LU1242518857.USD","BK4550","SG9999015358.SGD","LU0210533765.USD","LU2417539215.USD","LU0289961442.SGD","LU2322448791.USD","BK4579","NVD3.UK","LU0823417653.USD","LU0082616367.USD","LU2125909916.SGD","LU0267386448.USD","LU1316542783.SGD","LU2471134523.USD","LU2506951875.HKD","LU2506951792.HKD","NVDG","LU2237957811.SGD","LU0234570918.USD","LU2125154935.USD","LU0823414551.USD","LU1145028129.USD","BK4605","LU1721428933.USD","SG9999014021.USD","BK4614","LU1934455277.USD","LU0477156953.USD","SG9999015978.USD","LU0640476718.USD","IE00B19Z3581.USD","IE00B5949003.HKD","LU1868836591.USD","LU0128525929.USD","LU1791807156.HKD","LU2211815571.USD","LU2750360997.AUD","SG9999015986.USD","NVDS.UK","LU0823421333.USD","LU0006306889.USD","LU0494093205.USD","IE00BGHQF748.EUR","LU2089283258.USD","HK0000914686.HKD","BK4608","IE00BZ1G4Q59.USD","GB00B4LPDJ14.GBP","LU1645745479.HKD","LU2750360641.GBP","LU0889565833.HKD","LU1668664300.SGD","LU1236620834.HKD","LU1261432733.SGD","LU2065169927.USD","LU0820562030.AUD","LU0426412945.USD","SGXZ81514606.USD","IE00BKVL7J92.USD","BK4141","AIYY","LU0154236417.USD","BK4023","LU1066051811.HKD","IE00BQXX3C00.GBP","LU0072462426.USD","BK4585","SG9999015945.SGD","LU2125154778.USD","LU0994945656.USD","IE00BD6J9T35.USD","LU0345768153.USD","LU0965508806.USD","LU2360032135.SGD","LU1814569148.SGD","LU0106831901.USD","LU2242650005.HKD","LU1242518931.SGD","LU2413666699.HKD","LU0345774631.USD","LU1839511570.USD","BK4607","IE00BQXX3D17.EUR","LU2487616109.SGD","IE0034235295.USD","IE0004091025.USD","LU1923623000.USD","BK4184","SG9999014575.USD","NVIW.SI","LU2720916845.USD","LU1935042991.SGD","LU0476273544.USD","LU1823568750.SGD","LU1228905540.USD","LU1363072403.SGD","BK4534","LU2420271590.USD","LU1066051498.USD","LU2756315318.SGD","LU0882574139.USD","SG9999014559.SGD","BK4554","LU2210150020.SGD","LU2250418816.HKD","IE00BZ9MQY76.HKD","LU0348723411.USD","LU0238689110.USD","LU2083900584.USD","HK0000306701.USD","LU1868836757.USD","LU2491050071.SGD","LU1989764664.SGD","LU0466842654.USD","LU2125909247.SGD","LU0708995401.HKD","IE0034235188.USD","BK4561","LU0683600562.USD","SG9999018865.SGD","LU2023250843.SGD","IE00BKDWB100.SGD","LU1989772923.USD","BK4539","LU2506952097.USD","LU1232071149.USD","LU0056508442.USD","LU1861215975.USD","IE00BK4W5M84.HKD","LU0175139822.USD","IE0005OL40V9.USD","LU0823434740.USD","IE0034235303.USD","GB00BDT5M118.USD","IE000KEQY171.SGD","LU2860962120.EUR","LU1951200564.SGD","LU2458330169.SGD","BK4566","LU2108987350.USD","SG9999014880.SGD","IE00B19Z3B42.SGD","LU0225283273.USD","LU1804176565.USD","LU0719512351.SGD","LU2552382058.USD","LU0069063385.USD","LU0053666078.USD","LU1791710400.SGD","LU0642271901.SGD","LU0109392836.USD","LU1400636574.HKD","LU0211328371.USD","LU0215105999.USD","LU0266013472.USD","SG9999014039.USD","LU2746668461.USD","LU2111349929.HKD","BK4504","IE000YTNTUN2.SGD","LU0289739343.SGD","IE00BKPKM429.USD","LU0354030438.USD","LU2210149790.SGD","LU2491050154.USD","SG9999014013.SGD","LU2404859741.USD","SGXZ99366536.SGD","IE0002270589.USD","LU0080751232.USD","IE00BJLML261.HKD","IE00BSNM7G36.USD","BK4581","LU2452424414.USD","LU1069347547.HKD","LU2213496289.HKD","LU1934455863.HKD","LU0950375773.USD","LU2506952170.USD","BK4532","HK0000320264.USD","LU1815336760.USD","IE00B3M56506.USD","LU0545562505.USD","LU2065170008.USD","LU0210528500.USD","LU1670627923.USD","LU0124676726.USD","LU2106854487.HKD","LU2552382215.SGD","LU0444973449.USD","LU2095319765.USD","LU1121112475.USD","BK4543","LU0127658192.USD","LU0964807845.USD","LU2764263039.SGD","LU2505996509.AUD","APO","LU1852331112.SGD","LU1670628061.USD","IE00B894F039.SGD","LU1983260115.SGD","LU1629891620.HKD","LU1496350171.SGD","LU0011850046.USD","LU2471134796.USD","SG9999000418.SGD","LU0096362180.USD","LU1571399168.USD","LU1778281490.HKD","LU0061474960.USD","LU0198837287.USD","LU0276348264.USD","LU0345774391.USD","SGXZ31699556.SGD","LU2430703251.USD","LU2168564495.EUR","SG9999014005.SGD","LU0353189680.USD","BK4135","SG9999015952.SGD","LU2461242641.AUD","BK4127","IE000W1ABFV2.USD","LU0345769128.USD","LU0077335932.USD","LU0310799852.SGD","IE00BHPRN162.USD","SG9999002232.USD","SG9999014567.USD","IE0004445015.USD","LU1674673691.USD","LU2272731865.HKD","LU2244417387.USD","LU0971096721.USD","LU2471134952.CNY","LU0211327993.USD","BK4535","LU0786609619.USD","SG9999001077.SGD","LU1989772840.SGD","LU1084165304.USD","LU1720051108.HKD","IE00BJJMRY28.SGD","BK4528","LU1718418525.SGD","SG9999014898.SGD","LU2077746001.SGD","LU1127390331.HKD","LU0648001328.SGD","LU1244550221.USD","BK4503","LU1244550494.USD","LU1861127337.USD","LU0957808578.USD","BK4548","LU2931357623.SGD","ANV","LU0289960550.SGD","LU2247934214.USD","LU0985320562.USD","LU0048584097.USD","LU2191332357.HKD","LU1037948541.HKD","LU2286300806.USD","LU1201861249.SGD","LU2462157665.USD","LU0788109477.HKD","SGXZ23171101.USD","LU1551013342.USD","LU0965509010.AUD","LU0787776722.HKD","LU0354030511.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","LU0390134368.USD","LU2097344431.USD","LU2322448957.HKD","LU1989764748.USD","IE00B19Z9505.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU2237438978.USD","LU0965509101.SGD","BK4097","LU1366192091.USD","NVD","LU0210536198.USD","LU2294711713.HKD","LU1400636491.USD","LU2413666426.HKD","LU2552382132.HKD","LU1035773651.USD","LU0289941410.SGD","LU1267930490.SGD","LU0094547139.USD","IE00BMPRXN33.USD","LU0672654240.SGD","LU0417517546.SGD","BK4533","LU0690374615.EUR","LU1815333072.USD","LU2543165471.USD","LU0251142724.SGD","LU1267930573.SGD","LU0316494557.USD","IE00BYQQ9H92.USD","LU0265550946.USD","LU2237957902.USD","LU2756315664.SGD","LU1803068979.SGD","LU2505996681.GBP","LU2381873111.SGD","IE00BMPRXQ63.HKD","BK4567","LU0006061336.USD","LU2463028550.USD","BK4587","LU0234572021.USD","SG9999014542.SGD","LU2896262040.SGD","IE00B19Z9Z06.USD","LU1035775433.USD","LU1119994496.HKD","IE00BFXG0V08.USD","LU0820561818.USD","SNVD.UK","IE00BZ199S13.USD","LU0158827781.USD","LU1992135472.HKD","AXPG","LU0942090050.USD","LU0203202063.USD","LU1951198990.SGD","LU1935043023.USD","LU2168564065.EUR","LU0868494708.USD","LU1366333091.USD","LU2317271919.USD","LU0708994859.HKD","LU0342679015.USD","SG9999014906.USD","BK4106","BK4612","LU0310800379.SGD","SG9999015341.SGD","LU0557290698.USD","LU0096364046.USD","IE0001KFT4U8.USD","LU0823421416.USD","LU1064131342.USD","LU2360107671.USD","LU0061474705.USD","LU2125909593.SGD","LU2236285917.USD","IE00B4JS1V06.HKD","LU0957791311.USD","LU2168563687.JPY","LU0742534661.SGD","LU0106261372.USD","LU1551013425.SGD","IBM","LU1496350502.SGD","LU0724617625.USD","LU2506951958.HKD","SG9999002224.SGD","LU2471134879.HKD","LU1712237335.SGD","LU1116320901.HKD","LU2361044949.HKD","LU2242649171.HKD","LU2473716301.USD","SGXZ51526630.SGD","IE00BN29S564.USD","LU1720051017.SGD","LU2065171311.SGD","GB00B4QBRK32.GBP","LU2023250330.USD","LU2272731782.SGD","LU1153585028.USD","LU0689472784.USD","LU0107464264.USD","LU1043141396.HKD","HK0000306685.HKD","LU2404859667.USD","LU2097829019.USD","LU0353189763.USD","LU1868836914.USD","LU2361044865.SGD","SG9999017495.SGD","LU2087625088.SGD","IE00BMPRXR70.SGD"],"gpt_icon":1},{"id":"2620446240","title":"Chemomab Therapeutics sees cash runway through 1Q27","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446240","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620446240?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:11","pubTimestamp":1773922306,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents and short-term bank deposits were $10.4 million as of December 31, 2025 compared to $14.3 million as of December 31, 2024. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/chemomab-therapeutics-sees-cash-runway-through-1q27-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/chemomab-therapeutics-sees-cash-runway-through-1q27-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2620240562","title":"Kanzhun Limited Announces Shareholder Return Target Through Dividend Distribution And Extension And Upsizing Of Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2620240562","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620240562?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:10","pubTimestamp":1773922223,"startTime":"0","endTime":"0","summary":"March 19 (Reuters) - Kanzhun Ltd <2076.HK>::*KANZHUN LIMITED ANNOUNCES SHAREHOLDER RETURN TARGET THROUGH DIVIDEND DISTRIBUTION AND EXTENSION AND UPSIZING OF SHARE REPURCHASE PROGRAM*KANZHUN LTD: ON MA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nRSD48SBK6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B29SXG58.USD","LU2039709279.SGD","BK4503","BK4585","LU1688375341.USD","BK1095","BK4509","LU0359201612.USD","LU0359202008.SGD","BZ","BK4563","02076","BK4505","BK1150","BK4539","BK4588","BK4535","LU1023057109.AUD","BK4551","BK4077","BK4526","BK4130"],"gpt_icon":0},{"id":"1102486596","title":"COMEX Copper Futures Plunge 3.1% to $5.419 per Pound","url":"https://stock-news.laohu8.com/highlight/detail?id=1102486596","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102486596?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:05","pubTimestamp":1773921922,"startTime":"0","endTime":"0","summary":"On March 19, COMEX copper futures experienced a sharp decline, dropping 3.1% to settle at $5.419 per pound.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","LU1861220033.SGD","AIYY","IE00B19Z9Z06.USD","LU2250418816.HKD","IE00B894F039.SGD","BK4608","LU0353189763.USD","BK4528","BK4551","BK4587","BK4588","APP","LU2063271972.USD","LU1852331112.SGD","APPX","LU2360106780.USD","SINA","IE00BZ9MQY76.HKD","BK4539","LU2360107168.USD","BK4585","LU0097036916.USD","HGmain","LU0353189680.USD","LU0056508442.USD","LU1861215975.USD","LU2290526834.HKD","IE00B19Z9P08.USD","LU2087625088.SGD","AI","BK4543","BK4023"],"gpt_icon":0},{"id":"2620494247","title":"Mobix Labs Selected for Smart Munitions Anti-Drone Feasibility Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2620494247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620494247?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:01","pubTimestamp":1773921711,"startTime":"0","endTime":"0","summary":"Mobix Labs was selected by a major munitions manufacturer to support a feasibility program for next-generation smart munitions technology aimed at anti-drone applications.The work will evaluate technology intended to improve how certain munitions respond as they approach fast-moving aerial targets such as drones.The program is limited to feasibility evaluation and does not involve production or deployment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mobix Labs Inc. published the original content used to generate this news brief on March 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6N7Hmd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBX","BK4141","BK4539"],"gpt_icon":0},{"id":"2620252247","title":"Press Release: Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252247","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620252247?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"--Completed Successful FDA End-of-Phase 2 Meeting Following Positive Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis --. --Achieved Alignment with FDA on Clear and Efficient Pathway to Potential Approval for the Treatment of PSC--. --Multiple Scientific Presentations and Publications Raised Awareness of Nebokitug's Potential to Become the First Disease-Modifying Treatment for PSC and Its Relevance to Other Fibro-Inflammatory Conditions--. Dr. Mor added, \"Our discussions with potential strategic partners continue to advance as we progress activities required for the timely initiation of the Phase 3 trial in PSC. In parallel, we are evaluating additional therapeutic indications where nebokitug has generated robust preclinical efficacy signals, providing a strong mechanistic and translational rationale for future clinical development.\". trial assessing nebokitug for the treatment of PSC wa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","BK4539","PSC","BK4181","LU0149725797.USD","LU2237443978.SGD","IE00BZ1G4Q59.USD","INN","BK4006","DM0.SI","BK6053","IE00BFXG1179.USD","LENZ","BK4588","LU0882574139.USD","LABU","R","LU2746668974.SGD","BK4022","LU2237443382.USD","BK4232","CMC","IE00BKVL7J92.USD","BK4585","IE00BHPRN162.USD","LU0170899867.USD","LU0971096721.USD","LU0267386448.USD","LU2746668461.USD","LU2237443465.HKD","LU1363072403.SGD","LU2237443622.USD","BK4139","LU2237443895.HKD","BK4218","LU2237443549.SGD","CMMB","BK4007"],"gpt_icon":0},{"id":"2620247781","title":"Press Release: Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247781","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247781?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"SEATTLE, March 19, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.  , a clinical-stage biopharmaceutical company developing novel therapies in oncology and other rare diseases, today announces the engagement of Kathy Puyana Theall, M.D., as Medical Director - Breast Oncology, and Adebola Giwa, M.D., as Medical Director - Rare Diseases.  The addition of these two highly experienced physicians and clinical leaders meaningfully strengthens Atossa's ability to execute on its -endoxifen development strategy across both breast cancer and rare disease programs, including McCune-Albright syndrome  and Duchenne Muscular Dystrophy , as the Company advances toward key clinical and regulatory milestones.\"Atossa is at an important stage of growth,\" said Dr. Theall. \"The company's commitment to advancing innovative therapies in breast cancer strongly aligns with my experience and passion, and I look for","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1596574779.USD","LU1543694498.USD","R","BK4079","BK4086","LU1165135440.EUR","BK4120","TM","BK4232","LU1721427968.SGD","BK4099","LU1620156213.USD","BK4588","BK4139","03160","LU2413665964.HKD","Z","TISI","BK4585","LU2413666004.HKD","BK4555","LENZ","BK4539","LU1620156130.USD","MAS","LU0170899867.USD","BK4022","BK4551","SG9999001440.SGD","BK4548","BK4007","BK4604"],"gpt_icon":0},{"id":"2620228656","title":"Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228656","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228656?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., March  19, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258948/0/en/Grace-Therapeutics-to-Present-Data-on-the-Unmet-Medical-Needs-and-Potential-Benefits-of-GTx-104-in-the-Treatment-of-aSAH-at-Upcoming-Medical-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4082","BK4108","ICU","BK4007","RDI","BK4539","BK4139"],"gpt_icon":0},{"id":"2620247421","title":"Kanzhun announces shareholder return target","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247421","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247421?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:58","pubTimestamp":1773921484,"startTime":"0","endTime":"0","summary":"KANZHUN (BZ) announced that its board of directors has approved an amendment to its existing share repurchase program and a shareholder return targ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kanzhun-announces-shareholder-return-target-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kanzhun-announces-shareholder-return-target-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","BZ","BK4563","BK4535","LU1688375341.USD","BK4503","BK4588","LU0359201612.USD","BK4077","BK4505","BK4509","IE00B29SXG58.USD","LU2039709279.SGD","BK4539","BK4130","LU0359202008.SGD","LU1023057109.AUD","BK4551","BK4585"],"gpt_icon":0},{"id":"1145318363","title":"Capital Group Reduces Stake in BOSS ZHIPIN-W by Approximately 2.65 Million Shares at Average Price of HK$56.87","url":"https://stock-news.laohu8.com/highlight/detail?id=1145318363","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145318363?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:34","pubTimestamp":1773920070,"startTime":"0","endTime":"0","summary":"On March 17, The Capital Group Companies, Inc. sold approximately 2.65 million shares of BOSS ZHIPIN-W (02076) at an average price of HK$56.87 per share, totaling about HK$150 million. Following this...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","LU0359202008.SGD","LU2039709279.SGD","BK4077","BK4563","02076","LU1023057109.AUD","LU0359201612.USD","BK4535","BK4505","BK4509","BK4588","BK1150","BZ","LU1688375341.USD","BK4130","BK1095","BK4526","BK4539","IE00B29SXG58.USD","BK4503"],"gpt_icon":0},{"id":"2620242176","title":"Aveanna Healthcare Posts Strong Q4, Affirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2620242176","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620242176?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:30","pubTimestamp":1773919804,"startTime":"0","endTime":"0","summary":"An update from Aveanna Healthcare Holdings ( ($AVAH) ) is now available. Aveanna Healthcare reported strong fourth-quarter and full-year 2025 resul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-posts-strong-q4-affirms-2026-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-posts-strong-q4-affirms-2026-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4196","AVAH","HCSG","LU0029874061.USD","LABU","LU0128526141.USD","BK4581","XBI","BK4137","BK4539","BK4585","BK4588"],"gpt_icon":0},{"id":"2620228692","title":"Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228692","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228692?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:30","pubTimestamp":1773919800,"startTime":"0","endTime":"0","summary":"Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value of earlier diagnosis using CNSide as it enters U.S. commercializationHOUST","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258891/0/en/Plus-Therapeutics-to-Present-New-Analysis-at-ISPOR-Showing-CNSide-May-Reduce-Leptomeningeal-Metastases-Healthcare-Costs-by-40.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4202","XLV","CNS","XBI","LU0029874061.USD","BK4581","BK4139","BK4007","CSF","HCSG","BK4137","BK4588","LU0128526141.USD","LABU","NCI","BK4539","BK4585","BK4135"],"gpt_icon":0},{"id":"2620224400","title":"Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2620224400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620224400?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:21","pubTimestamp":1773919260,"startTime":"0","endTime":"0","summary":"Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate  of 52% in serous endometrial cancer . Late-breaking oral presentation and corporate KOL panel at ESGO 2026 highlighted strong ACR-368 data in serous EC, a high unmet need subtype responsible for 50% of EC mortality. Initiated Arm 3  and adding Arm 4  Phase 2b cohorts in all-comer  serous EC subjects. Initial Phase 1 ACR-2316 data in AP3-prioritized solid tumor types showed favorable tolerability and promising clinical activity, notably in heavily pre-treated lung cancer subjects. Cash, cash equivalents and marketable securities of $118.6 million as of December 31, 2025, expected to fund operations into the second quarter of 2027. WATERTOWN, Mass., March 19, 2026  -- Acrivon Therapeutics, Inc.  , a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3  platform deployed for rational ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139","LENZ","BK4007","BK4201","CLIA","EC","BK4539"],"gpt_icon":0},{"id":"2620440962","title":"Aveanna sees FY26 revenue $2.54B-$2.56B, consensus $2.56B","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620440962?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:15","pubTimestamp":1773918913,"startTime":"0","endTime":"0","summary":"Matt Buckhalter, Chief Financial Officer, commented, “2025 was a monumental year for Aveanna (AVAH). Our team delivered exceptional performance acr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aveanna-sees-fy26-revenue-2-54b-2-56b-consensus-2-56b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aveanna-sees-fy26-revenue-2-54b-2-56b-consensus-2-56b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","AVAH","BK4196"],"gpt_icon":0}],"pageSize":20,"totalPage":76,"pageCount":30,"totalSize":1507,"code":"91000000","status":"200"}]}}